REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $156,000 | -83.7% | 129,000 | 0.0% | 0.00% | -80.0% |
Q3 2015 | $958,000 | -29.9% | 129,000 | -32.5% | 0.01% | -16.7% |
Q2 2015 | $1,366,000 | -16.8% | 191,000 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $1,641,000 | -34.4% | 191,000 | -23.9% | 0.01% | -33.3% |
Q4 2014 | $2,502,000 | – | 251,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |